Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells

Soo-Jin Jeong1, Cynthia A Pise-Masison, Michael F Radonovich

  • 1Virus Tumor Biology Section, Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.

Oncogene
|July 12, 2005
PubMed

Insights

The AKT pathway promotes survival in HTLV-1-transformed cells by activating NF-kappaB and inhibiting p53. Blocking AKT function disrupts these survival signals, offering potential therapeutic targets.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Virology

Background:

  • Human T-lymphotropic virus type 1 (HTLV-1) infection is linked to adult T-cell leukemia/lymphoma.
  • AKT activation is crucial for cell survival and resistance to apoptosis.
  • The Tax protein of HTLV-1 plays a significant role in viral pathogenesis.

Purpose of the Study:

  • To investigate the role of AKT activation in HTLV-1-transformed cells.
  • To elucidate the relationship between Tax, AKT, NF-kappaB, and p53 signaling.
  • To explore AKT's contribution to cell survival in HTLV-1 infection.

Main Methods:

  • Overexpression of wild-type (WT) and kinase-dead (KD) AKT mutants.
  • Inhibition of AKT using LY294002 (PI3K/AKT inhibitor) and AKT siRNA.
  • Assessment of NF-kappaB and p53 activity.
  • Analysis of IKKbeta and p65 phosphorylation.
  • Evaluation of Bcl-xL expression.

Main Results:

  • AKT is activated in HTLV-1-transformed cells, with Tax mediating this activation.
  • AKT activation enhances Tax-induced NF-kappaB activation and p53 inhibition.
  • Blocking AKT function prevents NF-kappaB activation and restores p53 activity.
  • AKT influences p53 transcriptional activity and p65 phosphorylation at Ser-536.
  • AKT's prosurvival role is associated with Bcl-xL expression.

Conclusions:

  • AKT signaling is a key mediator of prosurvival pathways in HTLV-1-transformed cells.
  • Tax-mediated AKT activation contributes to NF-kappaB activation and p53 inhibition.
  • Targeting the AKT pathway may represent a therapeutic strategy for HTLV-1-associated malignancies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...